Preventive Effects of Protocatechuic Acid on LPS-Induced Inflammatory Response in Human Gingival Fibroblasts via Activating PPAR-γ

Inflammation. 2015;38(3):1080-4. doi: 10.1007/s10753-014-0073-1.

Abstract

Protocatechuic acid (PCA), a major metabolite of anthocyanins, has been shown to have antioxidant, antitumoral, and anti-inflammatory activities. In this study, we investigated the anti-inflammatory effects of PCA on lipopolysaccharide (LPS)-induced inflammatory response in human gingival fibroblasts (HGFs). The effects of PCA on LPS-induced inflammatory cytokines IL-6 and chemokines IL-8 in HGFs were detected by ELISA. The expression of NF-κB and PPAR-γ was detected by Western blot analysis. Our results demonstrated that PCA suppressed IL-6 and IL-8 production in LPS-stimulated HGFs. We also found that PCA inhibited LPS-induced NF-κB activation. Furthermore, the inhibition of PCA on LPS-induced IL-6 and IL-8 production can be reversed by PPAR-γ antagonist GW9662. In conclusion, the anti-inflammatory mechanism of PCA is associated with activating PPAR-γ, thereby inhibiting LPS-induced inflammatory response.

MeSH terms

  • Anilides / pharmacology
  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / pharmacology
  • Cell Survival / drug effects
  • Enzyme Activation / drug effects
  • Gingiva / cytology*
  • Humans
  • Hydroxybenzoates / pharmacology*
  • Inflammation / drug therapy*
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Lipopolysaccharides
  • NF-kappa B / metabolism
  • PPAR gamma / antagonists & inhibitors
  • PPAR gamma / metabolism*
  • Periodontal Diseases / drug therapy

Substances

  • 2-chloro-5-nitrobenzanilide
  • Anilides
  • Anti-Inflammatory Agents
  • Antioxidants
  • CXCL8 protein, human
  • Hydroxybenzoates
  • IL6 protein, human
  • Interleukin-6
  • Interleukin-8
  • Lipopolysaccharides
  • NF-kappa B
  • PPAR gamma
  • protocatechuic acid